Antiatherogenic effects of vitamin E: the search for the Holy Grail
- PMID: 19774218
- PMCID: PMC2747395
- DOI: 10.2147/vhrm.s5532
Antiatherogenic effects of vitamin E: the search for the Holy Grail
Abstract
Vitamin E, a naturally occurring antioxidant, has been found to reduce atherosclerotic lesion formation in animal models as well as cardiovascular morbidity in several observational studies. However, a number of case-control and prospective cohort studies failed to confirm its value in the primary and secondary prevention of morbidity and mortality from coronary artery disease. Several small or larger randomized interventional trials completed to date failed to resolve the conflict. Notably, even in large, well-conducted prospective epidemiologic studies, the potential effects of residual confounding may be on the same order of magnitude as the reported benefit. The response to vitamin E supplementation in specific patient subpopulations with chronic inflammation and/or higher degrees of oxidative stress has not been studied as yet. Therefore, further large randomized interventional trials are warranted to clarify accurately the role of vitamin E in the primary and secondary prevention of atherosclerotic coronary disease in these patient groups.
Keywords: anti-inflammatory; antioxidant; atherosclerosis; cardiovascular disease; vitamin E.
Comment in
-
On the antiatherogenic effects of vitamin E: the search for the Holy Grail.Vasc Health Risk Manag. 2010 Mar 3;6:69-71; author reply 71. doi: 10.2147/vhrm.s9289. Vasc Health Risk Manag. 2010. PMID: 20234781 Free PMC article. No abstract available.
Similar articles
-
Where Are we with Vitamin E?J Thromb Thrombolysis. 1998 Jul;5(3):209-214. doi: 10.1023/A:1008891809012. J Thromb Thrombolysis. 1998. PMID: 10767117
-
Why do homocysteine-lowering B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases?Cardiovasc Ther. 2012 Aug;30(4):227-33. doi: 10.1111/j.1755-5922.2011.00266.x. Epub 2011 Apr 1. Cardiovasc Ther. 2012. PMID: 21884001 Review.
-
Vitamin E and heart disease: basic science to clinical intervention trials.Free Radic Biol Med. 2000 Jan 1;28(1):141-64. doi: 10.1016/s0891-5849(99)00224-5. Free Radic Biol Med. 2000. PMID: 10656300 Review.
-
[Antioxidant vitamins in the treatment and prevention of cardiovascular diseases. Vitamin E].Vopr Pitan. 2003;72(6):45-51. Vopr Pitan. 2003. PMID: 14870590 Review. Russian.
-
What we learnt from randomized clinical trials and cohort studies of antioxidant vitamin? Focus on vitamin E and cardiovascular disease.Curr Pharm Biotechnol. 2006 Apr;7(2):69-72. doi: 10.2174/138920106776597649. Curr Pharm Biotechnol. 2006. PMID: 16724939 Review.
Cited by
-
Anything New under the Sun? An Update on Modulation of Bioactive Compounds by Different Wavelengths in Agricultural Plants.Plants (Basel). 2021 Jul 20;10(7):1485. doi: 10.3390/plants10071485. Plants (Basel). 2021. PMID: 34371687 Free PMC article. Review.
-
Therapeutic Efficacy of Antioxidants in Ameliorating Obesity Phenotype and Associated Comorbidities.Front Pharmacol. 2020 Aug 13;11:1234. doi: 10.3389/fphar.2020.01234. eCollection 2020. Front Pharmacol. 2020. PMID: 32903449 Free PMC article. Review.
-
Soluble guanylate cyclase redox state under oxidative stress conditions in isolated monkey coronary arteries.Pharmacol Res Perspect. 2016 Sep 16;4(5):e00261. doi: 10.1002/prp2.261. eCollection 2016 Oct. Pharmacol Res Perspect. 2016. PMID: 27713826 Free PMC article.
-
On the antiatherogenic effects of vitamin E: the search for the Holy Grail.Vasc Health Risk Manag. 2010 Mar 3;6:69-71; author reply 71. doi: 10.2147/vhrm.s9289. Vasc Health Risk Manag. 2010. PMID: 20234781 Free PMC article. No abstract available.
References
-
- Steinberg D. Oxidative modification of LDL and Atherogenesis. Circulation. 1997;95:1062–1071. - PubMed
-
- Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med. 1992;13:341–390. - PubMed
-
- Jha P, Flather M, Lonn E, Farkouh M, Yusuf S. The antioxidant vitamins and cardiovascular disease: a critical review of epidemiologic and clinical trial data. Ann Intern Med. 1995;123:860–872. - PubMed
-
- Gey KF, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr. 1991;53(1 Suppl):326S–334S. - PubMed
-
- Riemersma RA, Wood DA, Macintyre CC, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet. 1991;337:1–5. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical